September 4, 2019
US Merck is considering shedding jobs in Japan, apparently targeting sales and marketing staffers this time, despite the phenomenal growth it is enjoying with its immuno-oncology star Keytruda (pembrolizumab), informed sources told Jiho on September 3. According to the sources,...read more